ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 284 filers reported holding ICU MED INC in Q1 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $300,473,929 | -34.0% | 2,524,776 | -1.2% | 0.20% | -30.4% |
Q2 2023 | $455,515,820 | +7.8% | 2,556,347 | -0.2% | 0.28% | +1.4% |
Q1 2023 | $422,441,848 | +4.9% | 2,560,869 | +0.1% | 0.28% | -3.1% |
Q4 2022 | $402,711,597 | +6.5% | 2,557,226 | -49.0% | 0.29% | +1.8% |
Q3 2022 | $378,000,623 | -9.8% | 5,014,918 | +96.8% | 0.28% | -2.1% |
Q2 2022 | $418,919,000 | -24.0% | 2,548,328 | +2.9% | 0.29% | +8.6% |
Q1 2022 | $551,284,000 | +1.2% | 2,476,119 | +7.9% | 0.27% | +17.2% |
Q4 2021 | $544,667,000 | +1.4% | 2,294,880 | -0.3% | 0.23% | -3.4% |
Q3 2021 | $537,012,000 | +11.7% | 2,301,021 | -1.5% | 0.24% | +14.1% |
Q2 2021 | $480,567,000 | -3.6% | 2,335,116 | -3.7% | 0.21% | -9.6% |
Q1 2021 | $498,373,000 | -11.4% | 2,425,882 | -7.5% | 0.23% | -12.6% |
Q4 2020 | $562,756,000 | +4.5% | 2,623,694 | -11.0% | 0.26% | -7.1% |
Q3 2020 | $538,642,000 | +10.8% | 2,947,263 | +11.7% | 0.28% | +2.9% |
Q2 2020 | $486,285,000 | -13.0% | 2,638,409 | -4.7% | 0.27% | -28.9% |
Q1 2020 | $558,654,000 | +4.1% | 2,768,765 | -3.5% | 0.38% | +39.6% |
Q4 2019 | $536,711,000 | +17.2% | 2,868,271 | +0.0% | 0.28% | +10.9% |
Q3 2019 | $457,771,000 | -35.7% | 2,868,241 | +1.5% | 0.25% | -35.8% |
Q2 2019 | $711,856,000 | +10.7% | 2,825,836 | +5.2% | 0.39% | +8.4% |
Q1 2019 | $642,772,000 | +5.5% | 2,685,713 | +1.2% | 0.36% | -8.5% |
Q4 2018 | $609,385,000 | +57.2% | 2,653,767 | +93.6% | 0.39% | +87.9% |
Q3 2018 | $387,606,000 | -3.2% | 1,370,845 | +0.5% | 0.21% | -9.2% |
Q2 2018 | $400,354,000 | +15.3% | 1,363,370 | -0.9% | 0.23% | +11.2% |
Q1 2018 | $347,247,000 | +7.4% | 1,375,781 | -8.1% | 0.20% | +3.0% |
Q4 2017 | $323,229,000 | +3.3% | 1,496,432 | -11.1% | 0.20% | -1.0% |
Q3 2017 | $312,989,000 | +26.7% | 1,684,094 | +17.6% | 0.20% | +19.6% |
Q2 2017 | $247,072,000 | – | 1,432,301 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EVR Research LP | 22,000 | $4,719,000 | 3.86% |
NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |